Back to Search
JAMES ZWIEBEL, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1366868622Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D0025198(MD)
Research & Publications (20)
A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer.
PMID 19383814·Clin Cancer Res·2009
3-trial
Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma.
PMID 18854394·J Clin Endocrinol Metab·2009
3-trial
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.
PMID 19307505·J Clin Oncol·2009
3-trial
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
PMID 19225720·Invest New Drugs·2009
3-trial
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
PMID 19307957·Am J Clin Oncol·2009
3-trial
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
PMID 19671864·Clin Cancer Res·2009
3-trial
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
PMID 18764869·Br J Haematol·2008
3-trial
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
PMID 19047121·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9609 MEDICAL CENTER DR, ROOM 5W-460, MSC 9739
BETHESDA, MD 20892 - Phone
- (240) 276-6565
Quick Facts
- NPI
- 1366868622
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile